Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms

被引：0
|
作者：
Rui-Xia Xu
Jun Liu
Xiao-Lin Li
Sha Li
Yan Zhang
Yan-Jun Jia
Jing Sun
Jian-Jun Li
机构：
[1] FuWai Hospital,Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease
[2] National Center for Cardiovascular Disease,undefined
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
来源：
Journal of Translational Medicine | / 13卷
关键词：
Ezetimibe; PCSK9; Liver; Intestine; Kidney; Molecular mechanism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials
    Shuai Yang
    Wen Shen
    Hong-Zhou Zhang
    Chen-Xi Wang
    Ping-Ping Yang
    Qing-Hua Wu
    Cardiovascular Drugs and Therapy, 2023, 37 : 927 - 940
  • [32] High fat diet and PCSK9 knockout modulates lipid profile of the liver and changes the expression of lipid homeostasis related genes
    Nemeth, Krisztina
    Toth, Blanka
    Sarnyai, Farkas
    Koncz, Anna
    Lenzinger, Dorina
    Kereszturi, Eva
    Visnovitz, Tamas
    Kestecher, Brachyahu Meir
    Osteikoetxea, Xabier
    Csala, Miklos
    Buzas, Edit I.
    Tamasi, Viola
    NUTRITION & METABOLISM, 2023, 20 (01)
  • [33] High fat diet and PCSK9 knockout modulates lipid profile of the liver and changes the expression of lipid homeostasis related genes
    Krisztina Németh
    Blanka Tóth
    Farkas Sarnyai
    Anna Koncz
    Dorina Lenzinger
    Éva Kereszturi
    Tamás Visnovitz
    Brachyahu Meir Kestecher
    Xabier Osteikoetxea
    Miklós Csala
    Edit I. Buzás
    Viola Tamási
    Nutrition & Metabolism, 20
  • [34] Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ER?-mediated signaling pathway
    Jing, Yi
    Hu, Tianhui
    Yuan, Jun
    Liu, Zhikun
    Tao, Mingtao
    Ou, Mingyu
    Cheng, Xinru
    Cheng, Wei
    Yi, Yuanyuan
    Xiong, Qingping
    BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [35] Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE-/- Mice
    Gu, Lili
    Gong, Yaqin
    Zhao, Cheng
    Wang, Yue
    Tian, Qinghua
    Lei, Gaoxin
    Liang, Yalin
    Zhao, Wenfeng
    Tan, Shuhua
    MOLECULES, 2019, 24 (22):
  • [36] Untypical Metabolic Adaptations in Spontaneously Hypertensive Rats to Free Running Wheel Activity Includes Uncoupling Protein-3 (UCP-3) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Expression
    Wolf, Annemarie
    Kutsche, Hanna Sarah
    Atmanspacher, Felix
    Karadedeli, Meryem Sevval
    Schreckenberg, Rolf
    Schlueter, Klaus-Dieter
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [37] High-salt diet induces dyslipidemia through the SREBP2/PCSK9 pathway in dahl salt-sensitive rats
    Ou-Yang, Ya-nan
    Deng, Fen-fen
    Wang, Yun-jia
    Chen, Meng
    Yang, Peng-fei
    Yang, Zhe
    Tian, Zhongmin
    BIOCHIMIE, 2024, 216 : 34 - 45
  • [38] Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience
    Mandraffino, Giuseppe
    Scicali, Roberto
    Rodriguez-Carrio, Javier
    Savarino, Francesca
    Mamone, Federica
    Scuruchi, Michele
    Cinquegrani, Maria
    Imbalzano, Egidio
    Di Pino, Antonino
    Piro, Salvatore
    Rabuazzo, Agata Maria
    Squadrito, Giovanni
    Purrello, Francesco
    Saitta, Antonino
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (02) : 231 - 240
  • [39] Proprotein convertase PCSK9 affects expression of key surface proteins in human pancreatic beta cells via intracellular and extracellular regulatory circuits
    Saitoski, Kevin
    Ryaboshapkina, Maria
    Hamza, Ghaith M.
    Jarnuczak, Andrew F.
    Berthault, Claire
    Carlotti, Francoise
    Armanet, Mathieu
    Sengupta, Kaushik
    Underwood, Christina Rye
    Andersson, Shalini
    Guillas, Isabelle
    Le Goff, Wilfried
    Scharfmann, Raphael
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (07)
  • [40] PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid-lowering effects
    Palee, Siripong
    McSweeney, Christian M.
    Maneechote, Chayodom
    Moisescu, Dalila M.
    Jaiwongkam, Thidarat
    Kerdphoo, Sasiwan
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (11) : 7310 - 7319
12345